
© 2024 Edison Investment Research
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
06:26 | Argent BioPharma's CannEpil Approved in Germany | ||
Do | Argent BioPharma gains approval for prescription sales of CannEpil epilepsy treatment in Germany | ||
Mi | ARGENT BIOPHARMA LIMITED: CannEpil Receives Approval for Prescription in Germany | ||
16.03. | ARGENT BIOPHARMA LIMITED: CimetrA Phase IIb Clinical Trial Results | ||
11.03. | ARGENT BIOPHARMA LIMITED: Exclusive Agreement for Malta Manufacturing Facility |